
EVerZom, a French biotech company developing exosome-based therapies for regenerative medicine, has entered into a research and licensing agreement with …
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes

